BALPHARMA logo

Bal Pharma

(NSE: BALPHARMA)

BALPHARMA

94.45

0.00 (0.00%)

Bal Pharma Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Bal Pharma Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Bal Pharma Price Summary

Today High

95.9

Today Low

94

52 Week High

148.85

52 Week Low

85.25

Bal Pharma Fundamentals

Market Cap

172.9 Cr

CASA

0.0

No. Of Shares

1.5 Cr

P/E

8.8

P/B

1.0

Face Value

10.0

Dividend Yeild

1.9

Book Value

52.9

Net Interest Income

1.8 Cr

Cost to Income

NA

Promoter Holdings

49.6

EPS

6.14 L

CAR

NA

ROE

12.6

ROCE

12.6

Profit Growth

NA

Bal Pharma Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Bal Pharma

94.45

172.9 Cr

1.0

8.8

6.14 L

12.6

12.6

1.8 Cr

SMS Lifesciences

673.65

202.5 Cr

1.4

8.3

83.95 L

18.3

19.7

17.20 L

Lasa Supergenerics

37.8

216.8 Cr

1.5

10.7

5.60 L

15.2

17.1

4.90 L

Alpa Laboratories

61.45

128.1 Cr

1.1

10.4

6.71 L

11.3

15.5

1.5 Cr

Brooks Labs

113.3

219.9 Cr

2.4

0.0

-6.31 L

-19.2

-5.4

16.95 L

Vivimed Labs

10.15

125.2 Cr

0.1

0.0

-23.12 L

-3.6

2.7

NA

FAQ’s on Bal Pharma

About Bal Pharma

Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

The company exports APIs to countries like Japan, Australia, Spain, UK, Canada, Nigeria, Iceland, Slovenia, Romania, Argentina, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, Turkey, Egypt, Korea, Venezuela, Italy, Portugal, Morocco, Poland, Netherlands, Syria, Bangladesh, and Indonesia, etc.

It offers products for treatment for diabetes, cardiometabolics, gynaecology, dermatology, gastroenterology, orthopaedics, ENT and multi-speciality segments.

In India, the company operates its marketing through 5 divisions namely Multi-Specialty, Glyduz, Servetus, Bal Vedics and Zennova. It has distribution network of 1000 wholesalers that caters over 1,00,000 retailers.

The company produces range of APIs that includes Anti Histamine, Platelet inhibitor, Antidiabetic, Anti Convulsant, urinary incontinence, Neuropathic pain, Anti allergy, Anti inflammatory, Diuretic, Acne Treatment etc

Bal Pharma's R&D unit is engaged in developing processes for novel bulk actives (active pharmaceutical ingredients, APIs) and new chemical substances for therapeutic applications.

The company’s manufacturing facilities has been approved by WHO-GMP and has obtained the ISO 9001:2000 accreditations for quality management.

Businesses

  • API / Intermediates
  • Finished Formulations
  • Ayurvedic
  • Research and Development

Future Plans

Bal Pharma is planning to set up new facility in Uttaranchal, with an objective to enter into regulated markets. The company also plans to foray in the business of contract manufacturing.

Trade Bal Pharma today

Create a free portfolio in Trinkerr and earn and grow along with peers